Locations:
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Will enable sharper focus on new diagnostic tools for elusive neurodegenerative disease
Neuropsychological, serum and MRI measures improve over time relative to active fighters
Risk of agitation, delusions, personality change and more is shaped by early presentation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
$15.4M grant to fund work on atypical Alzheimer’s, Lewy body dementia and more
Both are essential, say updated International Working Group recommendations
New insights into shared inflammatory pathways and immune responses
TNFRSF1B gene variant associated with slower progression, offering potential drug target
Cohort study characterizes symptomatology by Alzheimer’s and Lewy body pathology
Advertisement
Advertisement
Search